Aralez Pharmaceuticals Inc. 4
4 · Aralez Pharmaceuticals Inc. · Filed Feb 8, 2016
Insider Transaction Report
Form 4
BARNHARDT JOHN E
VP, Finance and Administration
Transactions
- Tax Payment
Common Stock
2016-02-04$6.57/sh−13,682$89,891→ 74,106 total - Tax Payment
Common Stock
2016-02-04$6.57/sh−614$4,034→ 75,528 total - Exercise/Conversion
Stock Option
2016-02-04−2,036→ 0 totalExercise: $1.98From: 2012-10-03→ Common Stock (2,036 underlying) - Exercise/Conversion
Common Stock
2016-02-04$1.98/sh+2,036$4,031→ 76,142 total
Footnotes (3)
- [F1]Represents shares of common stock delivered following vesting of restricted stock units as payment of applicable taxes. The vesting of such restricted stock units was accelerated to February 4, 2016 pursuant to a merger agreement entered into by the registrant.
- [F2]Represents shares of common stock delivered following exercise of stock options as payment of applicable taxes.
- [F3]The expiration date of this Stock Option was accelerated to February 4, 2016 pursuant to a merger agreement entered into by the Registrant.